Molecular mechanisms for the evolution of the total peptide binding set in S100 proteins
S100 蛋白中总肽结合组进化的分子机制
基本信息
- 批准号:9320556
- 负责人:
- 金额:$ 28.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAlpha CellAmino Acid SequenceAmino AcidsAnimalsBindingBinding ProteinsBiochemicalBiologicalBiological ProcessBiologyBiophysical ProcessCalciumCellsCoupledDataDiseaseEnvironmentEvolutionFingerprintGene DuplicationGoalsHeart DiseasesHigh-Throughput Nucleotide SequencingHumanIn VitroInfluentialsLightMalignant NeoplasmsMeasuresModernizationMolecularMutationNatural SelectionsOrthologous GenePeptide MappingPeptidesPhage DisplayPhylogenetic AnalysisProcessPropertyProtein FragmentProteinsRecording of previous eventsRoleS100 ProteinsSamplingSignal TransductionSignaling ProteinSpecificityTestingTimeTissue ExtractsWorkbiophysical analysiscomputer studiesdeep sequencingduplicate genesexperimental studyinsightmemberprotein functionreconstructionresponse
项目摘要
PROJECT SUMMARY
The long-term goal of this project is to understand the ability of the proteins S100A5 and S100A6 to bind to
and recognize their target proteins. S100A5 and S100A6 are small proteins that bind to downstream target
proteins in the cell in response to calcium; however, the precise targets remain poorly understood. S100A5 and
S100A6 are both upregulated in disease states, including various cancers and heart disease; however, not
knowing their binding partners hampers efforts to understand the causes or consequences of this effect.
The first goal of the project is to identify possible binding targets using “phage display,” an approach for
identifying short protein fragments that may bind to the protein. This approach, while powerful, is also
plagued by false positive rates. To get around this, the project is guided by the words of a famous geneticist:
“nothing in biology makes sense except in light of evolution.” This means that averaging phage display/binding
results from the human proteins versus other animals amplifies the signal of biologically important protein
fragments. The second goal is to identify the pieces on S100A5 and S100A6 that are important for its
interactions with its possible targets. Revealing the evolutionary path by which a protein acquired its current
protein targets efficiently reveals the residues responsible and thus sets up mechanistic studies of its binding.
项目摘要
该项目的长期目标是了解蛋白质S100 A5和S100 A6结合蛋白的能力。
并识别它们的靶蛋白。S100 A5和S100 A6是与下游靶点结合的小蛋白,
蛋白质在细胞中响应钙;然而,精确的目标仍然知之甚少。S100 A5和
S100 A6在疾病状态中均上调,包括各种癌症和心脏病;然而,
了解其具有约束力的伙伴妨碍了理解这种影响的原因或后果的努力。
该项目的第一个目标是使用“噬菌体展示”来鉴定可能的结合靶点,
鉴定可与所述蛋白质结合的短蛋白质片段。这种方法虽然强大,
被假阳性率所困扰为了解决这个问题,该项目以一位著名遗传学家的话为指导:
“生物学中没有任何东西是有意义的,除非从进化的角度来看。”这意味着平均噬菌体展示/结合
人类蛋白质与其他动物蛋白质的对比结果放大了生物学上重要的蛋白质的信号
片段第二个目标是确定S100 A5和S100 A6上对其重要的部件,
与可能的目标之间的互动。揭示了蛋白质获得电流的进化路径
蛋白质靶标有效地揭示了负责的残基,从而建立了其结合的机理研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Jonathan Harms其他文献
Michael Jonathan Harms的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Jonathan Harms', 18)}}的其他基金
Evolution of new protein function in the multi-protein, multi-functional Toll-like receptor 4 complex
多蛋白、多功能Toll样受体4复合物中新蛋白功能的进化
- 批准号:
10625469 - 财政年份:2022
- 资助金额:
$ 28.95万 - 项目类别:
Molecular mechanisms for the evolution of the total peptide binding set in S100 proteins
S100 蛋白中总肽结合组进化的分子机制
- 批准号:
10000935 - 财政年份:2016
- 资助金额:
$ 28.95万 - 项目类别:
Molecular Mechanisms of the Evolution of Steroid Receptor-Ligand Interactions
类固醇受体-配体相互作用进化的分子机制
- 批准号:
8212332 - 财政年份:2010
- 资助金额:
$ 28.95万 - 项目类别:
Molecular Mechanisms of the Evolution of Steroid Receptor-Ligand Interactions
类固醇受体-配体相互作用进化的分子机制
- 批准号:
8034249 - 财政年份:2010
- 资助金额:
$ 28.95万 - 项目类别:
Molecular Mechanisms of the Evolution of Steroid Receptor-Ligand Interactions
类固醇受体-配体相互作用进化的分子机制
- 批准号:
7810279 - 财政年份:2010
- 资助金额:
$ 28.95万 - 项目类别:
相似海外基金
The Role of Arginine Transport on Pancreatic Alpha Cell Proliferation and Function
精氨酸转运对胰腺α细胞增殖和功能的作用
- 批准号:
10678248 - 财政年份:2023
- 资助金额:
$ 28.95万 - 项目类别:
Alpha cell-derived Extracellular Vesicles and Maternal Insulin Production
α细胞来源的细胞外囊泡和母体胰岛素的产生
- 批准号:
10681939 - 财政年份:2023
- 资助金额:
$ 28.95万 - 项目类别:
Targeting alpha-cell GPCRs to stimulate glucagon and counter hypoglycemia
靶向 α 细胞 GPCR 刺激胰高血糖素并对抗低血糖
- 批准号:
10427574 - 财政年份:2022
- 资助金额:
$ 28.95万 - 项目类别:
Regulation of alpha-cell glucagon secretion by mitochondrial anaplerosis-cataplerosis
线粒体回补-回补对α细胞胰高血糖素分泌的调节
- 批准号:
10607392 - 财政年份:2022
- 资助金额:
$ 28.95万 - 项目类别:
Arginine regulation of alpha cell proliferation and function
精氨酸调节α细胞增殖和功能
- 批准号:
10609909 - 财政年份:2022
- 资助金额:
$ 28.95万 - 项目类别:
Targeting alpha-cell GPCRs to stimulate glucagon and counter hypoglycemia
靶向 α 细胞 GPCR 刺激胰高血糖素并对抗低血糖
- 批准号:
10675646 - 财政年份:2022
- 资助金额:
$ 28.95万 - 项目类别:
Elucidating alpha cell defects in human type 1 diabetes using precision cut pancreas slice-on-a-chip coupled with high spatio-temporal microscopy
使用精密切割的胰腺切片结合高时空显微镜阐明人类 1 型糖尿病的 α 细胞缺陷
- 批准号:
457552 - 财政年份:2021
- 资助金额:
$ 28.95万 - 项目类别:
Studentship Programs
Defining alpha-cell proglucagon processing for type 2 diabetes treatment
定义 2 型糖尿病治疗的 α 细胞胰高血糖素原加工过程
- 批准号:
10331361 - 财政年份:2020
- 资助金额:
$ 28.95万 - 项目类别:
In vivo systems to discover mechanisms regulating human islet alpha cell function
体内系统发现调节人类胰岛α细胞功能的机制
- 批准号:
10623306 - 财政年份:2020
- 资助金额:
$ 28.95万 - 项目类别:
Deciphering alpha-cell heterogeneity using a novel reporter mouse
使用新型报告小鼠解读α细胞异质性
- 批准号:
20K08895 - 财政年份:2020
- 资助金额:
$ 28.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)